 | • レポートコード：GIR-107A14885 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ペメトレキセド薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペメトレキセド薬の種類別市場規模（凍結乾燥粉末/バイアル100mg、凍結乾燥粉末/バイアル500mg）、用途別市場規模（胸膜中皮腫、非小細胞肺がん）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ペメトレキセド薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly and Company、Pfizer、Teva、Eagle Pharmaceuticals、APOTEX、Qilu Pharmaceutical、Biocon ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：凍結乾燥粉末/バイアル100mg、凍結乾燥粉末/バイアル500mg ・用途別分析2016年-2026年：胸膜中皮腫、非小細胞肺がん ・ペメトレキセド薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ペメトレキセド薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ペメトレキセド薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ペメトレキセド薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ペメトレキセド薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pemetrexed Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pemetrexed Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Pemetrexed Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pemetrexed Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial
Market segment by Application can be divided into
Pleural mesothelioma
Non-small cell lung cancer
The key market players for global Pemetrexed Drug market are listed below:
Eli Lilly and Company
Pfizer
Teva
Eagle Pharmaceuticals
APOTEX
Qilu Pharmaceutical
Biocon
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pemetrexed Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pemetrexed Drug, with price, sales, revenue and global market share of Pemetrexed Drug in 2018 and 2019.
Chapter 3, the Pemetrexed Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pemetrexed Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pemetrexed Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pemetrexed Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Pemetrexed Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pemetrexed Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 100 mg lyophilized powder/vial
1.2.3 500 mg lyophilized powder/vial
1.3 Market Analysis by Application
1.3.1 Overview: Global Pemetrexed Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pleural mesothelioma
1.3.3 Non-small cell lung cancer
1.4 Global Pemetrexed Drug Market Size & Forecast
1.4.1 Global Pemetrexed Drug Sales in Value (2016-2026))
1.4.2 Global Pemetrexed Drug Sales in Volume (2016-2026)
1.4.3 Global Pemetrexed Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global Pemetrexed Drug Production Capacity Analysis
1.5.1 Global Pemetrexed Drug Total Production Capacity (2016-2026)
1.5.2 Global Pemetrexed Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pemetrexed Drug Market Drivers
1.6.2 Pemetrexed Drug Market Restraints
1.6.3 Pemetrexed Drug Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business
2.1.3 Eli Lilly and Company Pemetrexed Drug Product and Services
2.1.4 Eli Lilly and Company Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Pemetrexed Drug Product and Services
2.2.4 Pfizer Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Pemetrexed Drug Product and Services
2.3.4 Teva Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eagle Pharmaceuticals
2.4.1 Eagle Pharmaceuticals Details
2.4.2 Eagle Pharmaceuticals Major Business
2.4.3 Eagle Pharmaceuticals Pemetrexed Drug Product and Services
2.4.4 Eagle Pharmaceuticals Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 APOTEX
2.5.1 APOTEX Details
2.5.2 APOTEX Major Business
2.5.3 APOTEX Pemetrexed Drug Product and Services
2.5.4 APOTEX Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Qilu Pharmaceutical
2.6.1 Qilu Pharmaceutical Details
2.6.2 Qilu Pharmaceutical Major Business
2.6.3 Qilu Pharmaceutical Pemetrexed Drug Product and Services
2.6.4 Qilu Pharmaceutical Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Biocon
2.7.1 Biocon Details
2.7.2 Biocon Major Business
2.7.3 Biocon Pemetrexed Drug Product and Services
2.7.4 Biocon Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pemetrexed Drug Sales by Manufacturer
3.1 Global Pemetrexed Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pemetrexed Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pemetrexed Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Pemetrexed Drug Manufacturer Market Share
3.4.2 Top 6 Pemetrexed Drug Manufacturer Market Share
3.5 Global Pemetrexed Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pemetrexed Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pemetrexed Drug Market Size by Region
4.1.1 Global Pemetrexed Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Pemetrexed Drug Revenue by Region (2016-2026)
4.2 North America Pemetrexed Drug Revenue (2016-2026)
4.3 Europe Pemetrexed Drug Revenue (2016-2026)
4.4 Asia-Pacific Pemetrexed Drug Revenue (2016-2026)
4.5 South America Pemetrexed Drug Revenue (2016-2026)
4.6 Middle East and Africa Pemetrexed Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pemetrexed Drug Sales in Volume by Type (2016-2026)
5.2 Global Pemetrexed Drug Revenue by Type (2016-2026)
5.3 Global Pemetrexed Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pemetrexed Drug Sales in Volume by Application (2016-2026)
6.2 Global Pemetrexed Drug Revenue by Application (2016-2026)
6.3 Global Pemetrexed Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pemetrexed Drug Sales by Type (2016-2026)
7.2 North America Pemetrexed Drug Sales by Application (2016-2026)
7.3 North America Pemetrexed Drug Market Size by Country
7.3.1 North America Pemetrexed Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Pemetrexed Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pemetrexed Drug Sales by Type (2016-2026)
8.2 Europe Pemetrexed Drug Sales by Application (2016-2026)
8.3 Europe Pemetrexed Drug Market Size by Country
8.3.1 Europe Pemetrexed Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Pemetrexed Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pemetrexed Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Pemetrexed Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Pemetrexed Drug Market Size by Region
9.3.1 Asia-Pacific Pemetrexed Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pemetrexed Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pemetrexed Drug Sales by Type (2016-2026)
10.2 South America Pemetrexed Drug Sales by Application (2016-2026)
10.3 South America Pemetrexed Drug Market Size by Country
10.3.1 South America Pemetrexed Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Pemetrexed Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pemetrexed Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Pemetrexed Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Pemetrexed Drug Market Size by Country
11.3.1 Middle East & Africa Pemetrexed Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pemetrexed Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pemetrexed Drug Typical Distributors
12.3 Pemetrexed Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pemetrexed Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pemetrexed Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly and Company Major Business
Table 5. Eli Lilly and Company Pemetrexed Drug Product and Services
Table 6. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Pemetrexed Drug Product and Services
Table 10. Pfizer Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Pemetrexed Drug Product and Services
Table 14. Teva Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Eagle Pharmaceuticals Major Business
Table 17. Eagle Pharmaceuticals Pemetrexed Drug Product and Services
Table 18. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. APOTEX Basic Information, Manufacturing Base and Competitors
Table 20. APOTEX Major Business
Table 21. APOTEX Pemetrexed Drug Product and Services
Table 22. APOTEX Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Pharmaceutical Major Business
Table 25. Qilu Pharmaceutical Pemetrexed Drug Product and Services
Table 26. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Biocon Basic Information, Manufacturing Base and Competitors
Table 28. Biocon Major Business
Table 29. Biocon Pemetrexed Drug Product and Services
Table 30. Biocon Pemetrexed Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Pemetrexed Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Pemetrexed Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Pemetrexed Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Pemetrexed Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Pemetrexed Drug Production Site of Key Manufacturer
Table 36. Pemetrexed Drug New Entrant and Capacity Expansion Plans
Table 37. Pemetrexed Drug Mergers & Acquisitions in the Past Five Years
Table 38. Global Pemetrexed Drug Sales by Region (2016-2021e) & (K Units)
Table 39. Global Pemetrexed Drug Sales by Region (2021-2026) & (K Units)
Table 40. Global Pemetrexed Drug Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Pemetrexed Drug Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Pemetrexed Drug Sales by Type (2016-2021e) & (K Units)
Table 43. Global Pemetrexed Drug Sales by Type (2021-2026) & (K Units)
Table 44. Global Pemetrexed Drug Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Pemetrexed Drug Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Pemetrexed Drug Price by Type (2016-2021e) & (USD/Unit)
Table 47. Global Pemetrexed Drug Price by Type (2021-2026) & (USD/Unit)
Table 48. Global Pemetrexed Drug Sales by Application (2016-2021e) & (K Units)
Table 49. Global Pemetrexed Drug Sales by Application (2021-2026) & (K Units)
Table 50. Global Pemetrexed Drug Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Pemetrexed Drug Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Pemetrexed Drug Price by Application (2016-2021e) & (USD/Unit)
Table 53. Global Pemetrexed Drug Price by Application (2021-2026) & (USD/Unit)
Table 54. North America Pemetrexed Drug Sales by Country (2016-2021e) & (K Units)
Table 55. North America Pemetrexed Drug Sales by Country (2021-2026) & (K Units)
Table 56. North America Pemetrexed Drug Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Pemetrexed Drug Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Pemetrexed Drug Sales by Type (2016-2021e) & (K Units)
Table 59. North America Pemetrexed Drug Sales by Type (2021-2026) & (K Units)
Table 60. North America Pemetrexed Drug Sales by Application (2016-2021e) & (K Units)
Table 61. North America Pemetrexed Drug Sales by Application (2021-2026) & (K Units)
Table 62. Europe Pemetrexed Drug Sales by Country (2016-2021e) & (K Units)
Table 63. Europe Pemetrexed Drug Sales by Country (2021-2026) & (K Units)
Table 64. Europe Pemetrexed Drug Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Pemetrexed Drug Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Pemetrexed Drug Sales by Type (2016-2021e) & (K Units)
Table 67. Europe Pemetrexed Drug Sales by Type (2021-2026) & (K Units)
Table 68. Europe Pemetrexed Drug Sales by Application (2016-2021e) & (K Units)
Table 69. Europe Pemetrexed Drug Sales by Application (2021-2026) & (K Units)
Table 70. Asia-Pacific Pemetrexed Drug Sales by Region (2016-2021e) & (K Units)
Table 71. Asia-Pacific Pemetrexed Drug Sales by Region (2021-2026) & (K Units)
Table 72. Asia-Pacific Pemetrexed Drug Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Pemetrexed Drug Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Pemetrexed Drug Sales by Type (2016-2021e) & (K Units)
Table 75. Asia-Pacific Pemetrexed Drug Sales by Type (2021-2026) & (K Units)
Table 76. Asia-Pacific Pemetrexed Drug Sales by Application (2016-2021e) & (K Units)
Table 77. Asia-Pacific Pemetrexed Drug Sales by Application (2021-2026) & (K Units)
Table 78. South America Pemetrexed Drug Sales by Country (2016-2021e) & (K Units)
Table 79. South America Pemetrexed Drug Sales by Country (2021-2026) & (K Units)
Table 80. South America Pemetrexed Drug Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Pemetrexed Drug Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Pemetrexed Drug Sales by Type (2016-2021e) & (K Units)
Table 83. South America Pemetrexed Drug Sales by Type (2021-2026) & (K Units)
Table 84. South America Pemetrexed Drug Sales by Application (2016-2021e) & (K Units)
Table 85. South America Pemetrexed Drug Sales by Application (2021-2026) & (K Units)
Table 86. Middle East & Africa Pemetrexed Drug Sales by Country (2016-2021e) & (K Units)
Table 87. Middle East & Africa Pemetrexed Drug Sales by Country (2021-2026) & (K Units)
Table 88. Middle East & Africa Pemetrexed Drug Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Pemetrexed Drug Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Pemetrexed Drug Sales by Type (2016-2021e) & (K Units)
Table 91. Middle East & Africa Pemetrexed Drug Sales by Type (2021-2026) & (K Units)
Table 92. Middle East & Africa Pemetrexed Drug Sales by Application (2016-2021e) & (K Units)
Table 93. Middle East & Africa Pemetrexed Drug Sales by Application (2021-2026) & (K Units)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Pemetrexed Drug Typical Distributors
Table 97. Pemetrexed Drug Typical Customers
List of Figures
Figure 1. Pemetrexed Drug Picture
Figure 2. Global Pemetrexed Drug Sales Market Share by Type in 2020
Figure 3. 100 mg lyophilized powder/vial
Figure 4. 500 mg lyophilized powder/vial
Figure 5. Global Pemetrexed Drug Sales Market Share by Application in 2020
Figure 6. Pleural mesothelioma
Figure 7. Non-small cell lung cancer
Figure 8. Global Pemetrexed Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Pemetrexed Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Pemetrexed Drug Sales (2016-2026) & (K Units)
Figure 11. Global Pemetrexed Drug Price by Type (2016-2026) & (USD/Unit)
Figure 12. Global Pemetrexed Drug Production Capacity (2016-2026) & (K Units)
Figure 13. Global Pemetrexed Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Pemetrexed Drug Market Drivers
Figure 15. Pemetrexed Drug Market Restraints
Figure 16. Pemetrexed Drug Market Trends
Figure 17. Global Pemetrexed Drug Sales Market Share by Manufacturer in 2020
Figure 18. Global Pemetrexed Drug Revenue Market Share by Manufacturer in 2020
Figure 19. Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Pemetrexed Drug Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Pemetrexed Drug Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Pemetrexed Drug Sales Market Share by Region (2016-2026)
Figure 23. Global Pemetrexed Drug Revenue Market Share by Region (2016-2026)
Figure 24. North America Pemetrexed Drug Revenue (2016-2026) & (USD Million)
Figure 25. Europe Pemetrexed Drug Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Pemetrexed Drug Revenue (2016-2026) & (USD Million)
Figure 27. South America Pemetrexed Drug Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Pemetrexed Drug Revenue (2016-2026) & (USD Million)
Figure 29. Global Pemetrexed Drug Sales Market Share by Type (2016-2026)
Figure 30. Global Pemetrexed Drug Revenue Market Share by Type (2016-2026)
Figure 31. Global Pemetrexed Drug Price by Type (2016-2026) & (USD/Unit)
Figure 32. Global Pemetrexed Drug Sales Market Share by Application (2016-2026)
Figure 33. Global Pemetrexed Drug Revenue Market Share by Application (2016-2026)
Figure 34. Global Pemetrexed Drug Price by Application (2016-2026) & (USD/Unit)
Figure 35. North America Pemetrexed Drug Sales Market Share by Type (2016-2026)
Figure 36. North America Pemetrexed Drug Sales Market Share by Application (2016-2026)
Figure 37. North America Pemetrexed Drug Sales Market Share by Country (2016-2026)
Figure 38. North America Pemetrexed Drug Revenue Market Share by Country (2016-2026)
Figure 39. United States Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Pemetrexed Drug Sales Market Share by Type (2016-2026)
Figure 43. Europe Pemetrexed Drug Sales Market Share by Application (2016-2026)
Figure 44. Europe Pemetrexed Drug Sales Market Share by Country (2016-2026)
Figure 45. Europe Pemetrexed Drug Revenue Market Share by Country (2016-2026)
Figure 46. Germany Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Pemetrexed Drug Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Pemetrexed Drug Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Pemetrexed Drug Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Pemetrexed Drug Revenue Market Share by Region (2016-2026)
Figure 55. China Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Pemetrexed Drug Sales Market Share by Type (2016-2026)
Figure 62. South America Pemetrexed Drug Sales Market Share by Application (2016-2026)
Figure 63. South America Pemetrexed Drug Sales Market Share by Country (2016-2026)
Figure 64. South America Pemetrexed Drug Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Pemetrexed Drug Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Pemetrexed Drug Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Pemetrexed Drug Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Pemetrexed Drug Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Pemetrexed Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のペメトレキセド市場 2021：企業別、地域別、種類・用途別 The Pemetrexed market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …- 世界のペメトレキセド二ナトリウムAPI市場 2021：企業別、地域別、種類・用途別 The Pemetrexed Disodium API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の再構成薬剤用バイアルアダプター市場 2021：企業別、地域別、種類・用途別 The Vial Adaptors for Reconstitution Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界のスニチニブ薬市場 2021：企業別、地域別、種類・用途別 The Sunitinib Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界のNSCLC用標的薬物MEK阻害剤市場 2021：企業別、地域別、種類・用途別 The Targeted Drug MEK Inhibitors for NSCLC market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…